Le Lézard
Classified in: Health, Covid-19 virus
Subjects: PER, WOM, CFG, DEI

Prime Minister announces reappointment of Dr. Mona Nemer as Canada's Chief Science Advisor


OTTAWA, ON, July 4, 2024 /CNW/ -The Prime Minister, Justin Trudeau, today announced the reappointment of Dr. Mona Nemer as Canada's Chief Science Advisor for a term of three years, effective September 25, 2024.

A distinguished medical researcher, Dr. Nemer has served as Canada's Chief Science Advisor since 2017. In this role, she will continue to provide scientific advice to the federal government so that science is reflected in public policy. Her advice will ensure we have the evidence we need to make good decisions that help us grow the middle class and deliver fairness for every generation.

Scientists need to have a voice. They need to be able to speak freely about their work. And as we continue to see the devastating effects of climate change across the country, their work is more important than ever. From breakthroughs in life-saving medicine, to clean technology, to biodiversity preservation ? the discoveries that scientists make give us the tools we need to take better care of ourselves, of each other, and of the world around us.

Quotes

"We believe in science and for scientists to freely explore, discover, and ask questions. Over the past seven years, Dr. Nemer has provided invaluable advice to myself and my Cabinet to make scientific evidence a key part of public policy. I congratulate her on her reappointment and look forward to advancing our work together to make life better, fairer, and more prosperous for Canadians."

? The Rt. Hon. Justin Trudeau, Prime Minister of Canada

"Congratulations to Dr. Nemer on her reappointment as Canada's Chief Science Advisor. Dr. Nemer has played an important advisory role since 2017. Under her leadership, the network of ministerial scientific advisors across the government has grown, including the establishment of a youth council to assist Canada in its science policy considerations. I look forward to continuing to work with Dr. Nemer in advancing Canada's lead in research and innovation as well as inspiring the next generation of Canadian scientists."

? The Hon. François-Philippe Champagne, Minister of Innovation, Science and Industry

"Science and technology play vital roles in shaping a healthy and sustainable future for everyone. From dealing with wildfires and extreme weather events, to the responsible development of artificial intelligence, to preparing for future pandemics, science will inform the solutions that strengthen our society. It is an honour to continue in this role, contributing to the advancement of research and innovation across our country and ensuring that Canadians reap the full benefits of science."

? Dr. Mona Nemer, Canada's Chief Science Advisor

Quick Facts

Biographical Note

Associated Links

This document is also available at https://pm.gc.ca

 

SOURCE Prime Minister's Office


These press releases may also interest you

at 12:20
The "Regenerative Medicine Collaboration and Licensing Deals 2016-2024" report has been added to ResearchAndMarkets.com's offering. Regenerative Medicine Collaboration and Licensing Deals provides a comprehensive understanding and unprecedented...

at 12:10
The "Diagnostic Imaging Collaboration and Licensing Deals 2016-2024" report has been added to ResearchAndMarkets.com's offering. Diagnostic Imaging Collaboration and Licensing Deals provides a comprehensive understanding and unprecedented access to...

at 12:05
King Faisal Specialist Hospital & Research Centre (KFSH&RC) has achieved a significant milestone in its Robotic Cardiac Surgery Program, which was initiated in February 2019. Within its first year, the program performed 105 cardiac procedures. As of...

at 11:55
The "Infectious Vaccine Collaboration and Licensing Deals 2016-2024" report has been added to ResearchAndMarkets.com's offering. Infectious Vaccine Collaboration and Licensing Deals provides a comprehensive understanding and unprecedented access to...

at 11:40
The "Musculoskeletal Collaboration and Licensing Deals 2016-2024" report has been added to ResearchAndMarkets.com's offering. Musculoskeletal Collaboration and Licensing Deals provides a comprehensive understanding and unprecedented access to the...

at 11:30
The "Option and Evaluation Deals in Pharmaceuticals and Biotechnology 2016-2024" report has been added to ResearchAndMarkets.com's offering. Fully revised and updated, the report provides details of option and evaluation deals from 2016 to 2024....



News published on and distributed by: